Key facts
- This page summarizes Brian J. Caveney's Form 4 filing for LABCORP HOLDINGS INC. (LH).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Sep 2026, 08:07.
Brian J. Caveney - 01 Sep 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)
- Reporting relationship
- EVP, Pres of BLS, CMO & CSO
- Issuer ticker
- LH
- Reported as of
- 01 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Sep 2026, 08:07:22 UTC
- Prior SEC filing
- 30 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian J. Caveney filed Form 4 for LABCORP HOLDINGS INC. (LH) on 03 Sep 2026.
Change
- Previous filing in this sequence was filed on 30 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001717915
Primary reporting owner
Caveney Brian J
- Relationship
- EVP, Pres of BLS, CMO & CSO
- Address
- 531 SOUTH SPRING STREET, BURLINGTON
- Signature
- /s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney
- Signature date
- 03 Sep 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LH
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- Shares
- +3,000
- Change %
- +72%
- Price
- $0.000000*
- Shares after
- 7,170
- Date
- 01 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
Footnote F2
The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
Footnote F3
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.